Thursday, 03 April 2025, Virtual
Recording now available
About the webinar
Watch this Rhythm sponsored webinar to learn about the VENTURE trial results from 2 years of age and hear Professor Jesús Argente and Professor Carel Le Roux talk about the importance of early diagnosis and intervention in rare melanocortin-4 receptor (MC4R) pathway diseases.
KEY TOPICS:
During this Rhythm-sponsored webinar, Professor Jesús Argente (Hospital Infantil Universitario Niño Jesús, Madrid) and Professor Carel Le Roux (University College, Dublin) discuss about the VENTURE trial results from 2 years of age and the importance of early diagnosis and intervention in rare melanocortin-4 receptor (MC4R) pathway diseases
Prof Jesús Argente
Prof Carel Le Roux
Reproducir vídeoRhythm Pharmaceuticals utiliza la herramienta de Autenticación de Profesionales Sanitarios de IQVIA para comprobar su elegibilidad para acceder a este contenido audiovisual. Si ya dispone de una cuenta de IQVIA que utiliza con otros profesionales sanitarios, haga clic en 'Iniciar sesión'; de lo contrario, haga clic en 'Registrarse'.
Prof Jesús Argente
(Spain)
Prof Carel Le Roux
(Ireland)
IMCIVREE®▼ (setmelanotide) 10 mg/ml subcutaneous solution for injection. Indicated for the treatment of obesity and the control of hunger associated with genetically confirmed Bardet-Biedl syndrome (BBS), loss-of-function biallelic pro-opiomelanocortin (POMC), including PCSK1, deficiency or biallelic leptin receptor (LEPR) deficiency in adults and children 2 years of age and above. Proprietary: Rhythm Pharmaceuticals Netherlands B.V. Tel: +31 20 8546071.
Authorisation number EU/1/21/1564/0001. Funded by the National Health System and subject to medical prescription. Hospital use. 2,750 €/vial. Text revised in November 2024. Adverse events should be reported to Rhythm Pharmaceuticals and Pharmacovigilance of Medicinal Products for Human Use: http://www.notificaRAM.es.
▼This drug is subject to additional monitoring. For more information contact https://cima.aemps.es/cima/dochtml/ft/1211564001/FT_1211564001.html.
This webinar is fully organised and funded by Rhythm Pharmaceuticals Netherlands B.V. and is intended for healthcare professionals only. The session will include promotional content on Rhythm products.